[1] LIU X, WU Y, YANG Y, et al. Identical twins:one with anti-glomerular basement membrane glomerulonephritis,the other with systemic lupus erythematosus. BMC Nephrol. 2013;14:277.
[2] CAO J, YANG EB, SU JJ, et al. The tree shrews: adjuncts and alternatives to primates as models for biomedical research. J Med Primatol. 2003; 32(3):123-130.
[3] FAN Y, HUANG ZY, CAO CC, et al. Genome of the Chinese tree shrew. Nat Commun. 2013;4:1426.
[4] LI R, XU W, WANG Z, et al. Proteomic characteristics of the liver and skeletal muscle in the Chinese tree shrew (Tupaia belangeri chinensis). Protein Cell. 2012;3(9):691-700.
[5] VILLALTA D, BIZZARO N, BASSI N, et al. Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease. PLoS One. 2013;8(8):e71458.
[6] BHAT ZY, ZENG X, HINGORANI J, et al. Fibrillary glomerulonephritis in a patient with systemic lupus erythematosus: a rare association. Int Urol Nephrol. 2013;45(1):281-284.
[7] LIU RH, LI YQ, ZHOU WJ, et al. Supplementing mesenchymal stem cells improves the therapeutic effect of hematopoietic stem cell transplantation in the treatment of murine systemic lupus erythematosus. Transplant Proc. 2014;46(5):1621-1627.
[8] YANG GX, PAN LP, ZHOU QY, et al. Therapeutic effects of umbilical cord mesenchymal stem cells transplantation on systemic lupus erythematosus. Sichuan Da Xue Xue Bao Yi Xue Ban. 2014;45(2): 338-341,350.
[9] LU L, WANG DD, LI X, et al. Mechanism of umbilical cord mesenchymal stem cells in the up-regulation of regulatory T cells by transforming growth factor β1 in systemic lupus erythematosus. Zhonghua Yi Xue Za Zhi. 2013;93(13):980-983.
[10] SZMYRKA-KACZMAREK M, KOSMACZEWSKA A, CISZAK L, et al. Peripheral blood Th17/Treg imbalance in patients with low-active systemic lupus erythematosus. Postepy Hig Med Dosw (Online). 2014; 68:893-898.
[11] XIANG N, LI XP, LI XM, et al. Expression of Ets-1 and FOXP3 mRNA in CD4(+)CD25 (+) T regulatory cells from patients with systemic lupus erythematosus. Clin Exp Med. 2014;14(4):375-381.
[12] KATO H, PERL A. Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus. J Immunol. 2014; 192(9):4134-4144.
[13] LIN XJ, LUO M, CAI XY. Study of fas-mediated Foxp3+CD4+CD25+ Treg cell apoptosis in patients with systemic lupus erythematosus. Zhonghua Yi Xue Za Zhi. 2011;91(9):586-590.
[14] IZUI S, LAMBERT PH, FOURNIÉ GJ, et al. Features of systemic lupus erythematosus in mice injected with bacterial lipopolysaccharides: identificantion of circulating DNA and renal localization of DNA-anti-DNA complexes.J Exp Med. 1977;145(5):1115-1130.
[15] CAVALLO T, GOLDMAN M, LAMBERT PH. Animal model of human disease. Proliferative glomerulonephritis associated with polyclonal B-cell activation. Am J Pathol. 1984;114(2):346-348.
[16] RAMOS-NIEMBRO F, FOURNIÉ G, LAMBERT PH. Induction of circulating immune complexes and their renal localization after acute or chronic polyclonal B-cell activation in mice. Kidney Int Suppl.1982; 11:S29-38.
[17] SATOH M, HAMILTON KJ, AJMANI AK, et al. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane. J Immunol. 1996;157(7):3200-3206.
[18] SATOH M, KUMAR A, KANWAR YS, et al. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc Natl Acad Sci U S A.1995;92(24): 10934-10938.
[19] SATOH M, REEVES WH. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med. 1994; 180(6):2341-2346.
[20] MARTIN JC, BAETEN DL, JOSIEN R. Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus. Clin Immunol. 2014; 154(1):1-12.
|